Grace Therapeutics (GRCE) Current Ratio

Annual Current Ratio

14.26
+5.67+66.01%

March 1, 2024


Summary


Performance

GRCE Current Ratio Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGRCEfinancial healthmetrics:

Quarterly Current Ratio

6.01
-1.85-23.54%

September 1, 2024


Summary


Performance

GRCE Quarterly Current Ratio Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGRCEfinancial healthmetrics:

Current Ratio Formula

Current Ratio =  
Current Assets
Current Liabilities

GRCE Current Ratio Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+66.0%-60.4%
3 y3 years-63.9%-39.0%
5 y5 years+595.6%+232.0%

GRCE Current Ratio Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-63.9%+66.0%-70.9%at low
5 y5-year-63.9%+595.6%-84.8%+190.3%
alltimeall time-63.9%+7822.2%-84.8%+5910.0%

Grace Therapeutics Current Ratio History

DateAnnualQuarterly
Sep 2024
-
6.01(-23.5%)
Jun 2024
-
7.86(-44.9%)
Mar 2024
14.26(+66.0%)
14.26(-6.1%)
Dec 2023
-
15.19(-26.5%)
Sep 2023
-
20.68(+72.2%)
Jun 2023
-
12.01(+39.8%)
Mar 2023
8.59(-38.2%)
8.59(-11.8%)
Dec 2022
-
9.74(-1.2%)
Sep 2022
-
9.86(-11.4%)
Jun 2022
-
11.13(-19.9%)
Mar 2022
13.89(-64.8%)
13.89(-17.9%)
Dec 2021
-
16.91(+38.7%)
Sep 2021
-
12.19(-52.7%)
Jun 2021
-
25.75(-34.8%)
Mar 2021
39.50(+1480.0%)
39.50(+194.1%)
Dec 2020
-
13.43(+266.9%)
Sep 2020
-
3.66(+56.4%)
Jun 2020
-
2.34(-6.4%)
Mar 2020
2.50(+22.0%)
2.50(+20.8%)
Dec 2019
-
2.07(+14.4%)
Sep 2019
-
1.81(+12.4%)
Jun 2019
-
1.61(-21.5%)
Mar 2019
2.05(+44.4%)
2.05(-40.6%)
Dec 2018
-
3.45(+516.1%)
Sep 2018
-
0.56(-58.5%)
Jun 2018
-
1.35(-4.9%)
Mar 2018
1.42(-70.5%)
1.42(-47.4%)
Dec 2017
-
2.70(+56.1%)
Sep 2017
-
1.73(-56.3%)
Jun 2017
-
3.96
DateAnnualQuarterly
Mar 2017
4.81(-51.6%)
-
Nov 2016
-
3.51(-39.0%)
Aug 2016
-
5.75(-0.7%)
May 2016
-
5.79(-41.7%)
Feb 2016
9.93(-18.0%)
9.93(+9.1%)
Nov 2015
-
9.10(-32.2%)
Aug 2015
-
13.43(+62.0%)
May 2015
-
8.29(-31.5%)
Feb 2015
12.11(-45.1%)
12.11(+14.2%)
Nov 2014
-
10.60(+12.8%)
Aug 2014
-
9.40(-27.5%)
May 2014
-
12.96(-41.2%)
Feb 2014
22.05(+818.8%)
22.05(+1960.7%)
Nov 2013
-
1.07(-17.7%)
Aug 2013
-
1.30(-24.4%)
May 2013
-
1.72(-28.3%)
Feb 2013
2.40(-65.9%)
2.40(-26.4%)
Nov 2012
-
3.26(-34.9%)
Aug 2012
-
5.01(0.0%)
May 2012
-
5.01(-28.7%)
Feb 2012
7.03(+998.4%)
7.03(+8.7%)
Nov 2011
-
6.47(+482.9%)
Aug 2011
-
1.11(-50.0%)
May 2011
-
2.22(+246.9%)
Feb 2011
0.64(+255.6%)
0.64(-19.0%)
Nov 2010
-
0.79(+690.0%)
Aug 2010
-
0.10(-28.6%)
May 2010
-
0.14(-22.2%)
Feb 2010
0.18
0.18(-21.7%)
Nov 2009
-
0.23

FAQ

  • What is Grace Therapeutics annual current ratio?
  • What is the all time high annual current ratio for Grace Therapeutics?
  • What is Grace Therapeutics annual current ratio year-on-year change?
  • What is Grace Therapeutics quarterly current ratio?
  • What is the all time high quarterly current ratio for Grace Therapeutics?
  • What is Grace Therapeutics quarterly current ratio year-on-year change?

What is Grace Therapeutics annual current ratio?

The current annual current ratio of GRCE is 14.26

What is the all time high annual current ratio for Grace Therapeutics?

Grace Therapeutics all-time high annual current ratio is 39.50

What is Grace Therapeutics annual current ratio year-on-year change?

Over the past year, GRCE annual current ratio has changed by +5.67 (+66.01%)

What is Grace Therapeutics quarterly current ratio?

The current quarterly current ratio of GRCE is 6.01

What is the all time high quarterly current ratio for Grace Therapeutics?

Grace Therapeutics all-time high quarterly current ratio is 39.50

What is Grace Therapeutics quarterly current ratio year-on-year change?

Over the past year, GRCE quarterly current ratio has changed by -9.18 (-60.43%)